» Articles » PMID: 37626097

Linking Environmental Risk Factors with Epigenetic Mechanisms in Parkinson's Disease

Overview
Date 2023 Aug 25
PMID 37626097
Authors
Affiliations
Soon will be listed here.
Abstract

Sporadic Parkinson's disease (PD) is a progressive neurodegenerative disease, with a complex risk structure thought to be influenced by interactions between genetic variants and environmental exposures, although the full aetiology is unknown. Environmental factors, including pesticides, have been reported to increase the risk of developing the disease. Growing evidence suggests epigenetic changes are key mechanisms by which these environmental factors act upon gene regulation, in disease-relevant cell types. We present a systematic review critically appraising and summarising the current body of evidence of the relationship between epigenetic mechanisms and environmental risk factors in PD to inform future research in this area. Epigenetic studies of relevant environmental risk factors in animal and cell models have yielded promising results, however, research in humans is just emerging. While published studies in humans are currently relatively limited, the importance of the field for the elucidation of molecular mechanisms of pathogenesis opens clear and promising avenues for the future of PD research. Carefully designed epidemiological studies carried out in PD patients hold great potential to uncover disease-relevant gene regulatory mechanisms. Therefore, to advance this burgeoning field, we recommend broadening the scope of investigations to include more environmental exposures, increasing sample sizes, focusing on disease-relevant cell types, and recruiting more diverse cohorts.

Citing Articles

Escherichia Coli K1-colibactin meningitis induces microglial NLRP3/IL-18 exacerbating H3K4me3-synucleinopathy in human inflammatory gut-brain axis.

Tran V, Zhu X, Jamsranjav A, Lee L, Cho H Commun Biol. 2025; 8(1):382.

PMID: 40050667 PMC: 11885818. DOI: 10.1038/s42003-025-07787-5.


Parkinson's disease-associated alterations in DNA methylation and hydroxymethylation in human brain.

Choza J, Virani M, Kuhn N, Adams M, Kochmanski J, Bernstein A bioRxiv. 2025; .

PMID: 39975085 PMC: 11838189. DOI: 10.1101/2024.05.21.595193.


Investigating Parkinson's disease risk across farming activities using data mining and large-scale administrative health data.

Petit P, Berger F, Bonneterre V, Vuillerme N NPJ Parkinsons Dis. 2025; 11(1):13.

PMID: 39779703 PMC: 11711245. DOI: 10.1038/s41531-024-00864-2.


Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues.

Firdaus Z, Li X Int J Mol Sci. 2024; 25(21).

PMID: 39519209 PMC: 11546397. DOI: 10.3390/ijms252111658.


Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics.

Fisher R, Torrente M Front Mol Neurosci. 2024; 17:1456052.

PMID: 39346681 PMC: 11427407. DOI: 10.3389/fnmol.2024.1456052.


References
1.
Ren L, Yi J, Yang J, Li P, Cheng X, Mao P . Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis. Medicine (Baltimore). 2018; 97(37):e12172. PMC: 6155958. DOI: 10.1097/MD.0000000000012172. View

2.
Song C, Kanthasamy A, Jin H, Anantharam V, Kanthasamy A . Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology. 2011; 32(5):586-95. PMC: 3407036. DOI: 10.1016/j.neuro.2011.05.018. View

3.
Chatzidiakou L, Krause A, Han Y, Chen W, Yan L, Popoola O . Using low-cost sensor technologies and advanced computational methods to improve dose estimations in health panel studies: results of the AIRLESS project. J Expo Sci Environ Epidemiol. 2020; 30(6):981-989. DOI: 10.1038/s41370-020-0259-6. View

4.
Shu L, Qin L, Min S, Pan H, Zhong J, Guo J . Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson's disease. Neurobiol Aging. 2019; 84:242.e13-242.e16. DOI: 10.1016/j.neurobiolaging.2019.02.025. View

5.
Goldman J, Yen S, Chiu F, Peress N . Lewy bodies of Parkinson's disease contain neurofilament antigens. Science. 1983; 221(4615):1082-4. DOI: 10.1126/science.6308771. View